APA (7th ed.) Citation

Wingen-Heimann, S. M., Lübbert, C., Bavaro, D. F., & Hopff, S. M. (2025). Clostridioides difficile Infection in the United States of America—A Comparative Event Risk Analysis of Patients Treated with Fidaxomicin vs. Vancomycin Across 67 Large Healthcare Providers. Infectious Disease Reports, 17(4), 87. https://doi.org/10.3390/idr17040087

Chicago Style (17th ed.) Citation

Wingen-Heimann, Sebastian M., Christoph Lübbert, Davide Fiore Bavaro, and Sina M. Hopff. "Clostridioides Difficile Infection in the United States of America—A Comparative Event Risk Analysis of Patients Treated with Fidaxomicin Vs. Vancomycin Across 67 Large Healthcare Providers." Infectious Disease Reports 17, no. 4 (2025): 87. https://doi.org/10.3390/idr17040087.

MLA (9th ed.) Citation

Wingen-Heimann, Sebastian M., et al. "Clostridioides Difficile Infection in the United States of America—A Comparative Event Risk Analysis of Patients Treated with Fidaxomicin Vs. Vancomycin Across 67 Large Healthcare Providers." Infectious Disease Reports, vol. 17, no. 4, 2025, p. 87, https://doi.org/10.3390/idr17040087.